Lars Nepper‐Christensen

Author

Rigshospitalet ORCID

Also Known As

L Nepper-Christensen, L. Nepper-Christensen, Lars Nepper-Christensen, Lars Nepper‐Christensen, Reza Jabbari

Publications

715

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Zealand University Hospital Copenhagen University Hospital Lund University Aarhus University Hospital

About

Lars Nepper‐Christensen is an author at Rigshospitalet specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	223
2	Public Health	2	2	33
3	Emergency Medicine	2	2	104
4	Diabetes	1	1	85
5	Pharmacology	1	1	16

Lars Nepper‐Christensen

Publications

627

Citations

H-Index

Page 1

	Year	Citations
Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist, JAMA Cardiology	2017	127
Impact of Acute Hyperglycemia on Myocardial Infarct Size, Area at Risk, and Salvage in Patients With STEMI and the Association With Exenatide Treatment: Results From a Randomized Study Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, Diabetes Heart FailureAcute HyperglycemiaExenatide TreatmentCoronary Artery DiseaseAcute Myocardial Infarction	2014	85
Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Lars Nepper‐Christensen, Jacob Lønborg, Kiril Aleksov Ahtarovski, Journal of the American Heart Association	2017	55
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment–Elevation Myocardial Infarction Lars Nepper‐Christensen, Jacob Lønborg, Dan Eik Høfsten, Circulation Cardiovascular Interventions	2018	48
Myocardial Damage in Patients With Deferred Stenting After STEMI Jacob Lønborg, Thomas Engstrøm, Kiril Aleksov Ahtarovski, Journal of the American College of Cardiology Percutaneous Coronary InterventionHeart FailureCardiovascular DiseaseCardiologySurgery	2017	47
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial Thomas Engstrøm, Lars Nepper‐Christensen, Steffen Helqvist, Heart	2018	28
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Kasper Kyhl, Kiril Aleksov Ahtarovski, Lars Nepper‐Christensen, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionCardiovascular DiseaseOphthalmologyAtherosclerosisAcute Myocardial Infarction	2019	23
Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction Anna F. Thomsen, Litten Bertelsen, Christian Jøns, EP Europace	2022	21
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention Jasmine Melissa Madsen, Henning Kelbæk, Lars Nepper‐Christensen, EuroIntervention Percutaneous Coronary InterventionHeart FailureImmediate StentingCardiovascular DiseaseAtherosclerosis	2022	19
Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI Kathrine Ekström, Lars Nepper‐Christensen, Kiril Aleksov Ahtarovski, JACC. Cardiovascular imaging Heart FailureCardiovascular DiseaseMyocardial InfarctionAcute Myocardial InfarctionPublic Health	2019	18

Page 1